4/10
12:38 am
nktr
Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test [Seeking Alpha]
Low
Report
Nektar Therapeutics Sees Something In The Data And Puts Its Drug To The Test [Seeking Alpha]
4/3
01:21 pm
nktr
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
3/22
02:37 pm
nktr
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
Low
Report
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference [Yahoo! Finance]
3/22
02:00 pm
nktr
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Low
Report
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
3/6
02:37 pm
nktr
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata [Yahoo! Finance]
Low
Report
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata [Yahoo! Finance]
3/6
10:31 am
nktr
Nektar Therapeutics (NASDAQ: NKTR) had its price target raised by analysts at Jefferies Financial Group Inc. from $0.50 to $1.00. They now have a "hold" rating on the stock.
Low
Report
Nektar Therapeutics (NASDAQ: NKTR) had its price target raised by analysts at Jefferies Financial Group Inc. from $0.50 to $1.00. They now have a "hold" rating on the stock.
3/5
12:12 pm
nktr
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat [Yahoo! Finance]
Medium
Report
Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat [Yahoo! Finance]
3/5
11:35 am
nktr
Nektar Therapeutics (NASDAQ: NKTR) had its "market perform" rating re-affirmed by analysts at William Blair.
Medium
Report
Nektar Therapeutics (NASDAQ: NKTR) had its "market perform" rating re-affirmed by analysts at William Blair.
3/5
09:17 am
nktr
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata [Yahoo! Finance]
Low
Report
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata [Yahoo! Finance]
3/5
09:00 am
nktr
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata
Low
Report
Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata
3/4
05:08 pm
nktr
Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results [Yahoo! Finance]
Low
Report
Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results [Yahoo! Finance]
3/4
04:15 pm
nktr
Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
Low
Report
Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results
3/4
08:42 am
nktr
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX [Yahoo! Finance]
Medium
Report
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX [Yahoo! Finance]
3/4
08:30 am
nktr
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
High
Report
Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
2/27
06:00 pm
nktr
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
Medium
Report
Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference
2/26
06:00 pm
nktr
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
High
Report
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets
2/20
11:11 am
nktr
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know [Yahoo! Finance]
Low
Report
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know [Yahoo! Finance]
2/16
09:06 am
nktr
Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Medium
Report
Is Nektar Therapeutics (NASDAQ:NKTR) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]